Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01769469 · ClinicalTrials.gov registry record
Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 101
- Enrollment target
NCT01769469 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 101 participants.
The verdict
NCT01769469 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
This is a prospective observational cohort sub-study of subjects enrolled in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110 (NCT01772823) or ATN 113 (NCT01769456), which is a prospective interventional trial.
Interventions
- DRUG FTC/TDF (Truvada®)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01769469
The ClinicalTrials.gov registry entry for NCT01769469 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FTC/TDF (Truvada®) is the first listed.
NCT01769469 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01769469 about?
NCT01769469 is a clinical study titled "Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).". This is a prospective observational cohort sub-study of subjects enrolled in the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 110 (NCT01772823) or ATN 113 (NCT01769456), which is a prospective interventional trial.
What is the current status of trial NCT01769469?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01769469?
The interventions under investigation include: FTC/TDF (Truvada®) (DRUG).
Who is sponsoring clinical trial NCT01769469?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.